JAK inhibitors and risk of B-cell lymphomas

Blood. 2019 May 23;133(21):2251-2253. doi: 10.1182/blood-2019-03-900951.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Janus Kinase Inhibitors*
  • Lymphoma*
  • Lymphoma, B-Cell*
  • Myeloproliferative Disorders*

Substances

  • Janus Kinase Inhibitors